ABILIFY 7,5 mg/ml, solution injectable

Business Listing - September 04, 2021

ABILIFY 7,5 mg/ml, solution injectable

ABILIFY 7,5 mg/ml, solution injectable solution injectable intramusculaire Autorisation active Procédure centralisée Commercialisée 10/4/2006 OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)

Tags & Categories

active solution injectable autorisation procédure commercialisée intramusculaire centralisée abilify otsuka

Featured

This is a premium business listing. Stand out from the competition!

Own a Business?

List your company and reach more customers today.

Add Your Business